Annual revenue:
$54.10B+$8.28B(+18.08%)Summary
- As of today (August 18, 2025), AZN annual revenue is $54.10 billion, with the most recent change of +$8.28 billion (+18.08%) on December 31, 2024.
- During the last 3 years, AZN annual revenue has risen by +$16.26 billion (+42.99%).
- AZN annual revenue is now at all-time high.
Performance
AZN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$14.63B+$1.04B(+7.65%)Summary
- As of today (August 18, 2025), AZN quarterly revenue is $14.63 billion, with the most recent change of +$1.04 billion (+7.65%) on June 30, 2025.
- Over the past year, AZN quarterly revenue has increased by +$1.69 billion (+13.06%).
- AZN quarterly revenue is now -0.85% below its all-time high of $14.75 billion, reached on December 31, 2024.
Performance
AZN Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$56.53B+$1.69B(+3.08%)Summary
- As of today (August 18, 2025), AZN TTM revenue is $56.53 billion, with the most recent change of +$1.69 billion (+3.08%) on June 30, 2025.
- Over the past year, AZN TTM revenue has increased by +$7.40 billion (+15.06%).
- AZN TTM revenue is now at all-time high.
Performance
AZN TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AZN Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.1% | +13.1% | +15.1% |
| 3 y3 years | +43.0% | +35.8% | +28.1% |
| 5 y5 years | +121.8% | +131.2% | +111.4% |
AZN Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +43.0% | -0.8% | +35.8% | at high | +29.0% |
| 5 y | 5-year | at high | +121.8% | -0.8% | +131.2% | at high | +111.4% |
| alltime | all time | at high | +711.5% | -0.8% | +853.8% | at high | +3133.3% |
AZN Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $14.63B(+7.7%) | $56.53B(+3.1%) |
| Mar 2025 | - | $13.59B(-7.9%) | $54.84B(+1.7%) |
| Dec 2024 | $54.10B(+18.1%) | $14.75B(+8.8%) | $53.93B(+5.3%) |
| Sep 2024 | - | $13.56B(+4.8%) | $51.21B(+4.2%) |
| Jun 2024 | - | $12.94B(+2.0%) | $49.13B(+3.2%) |
| Mar 2024 | - | $12.68B(+5.4%) | $47.61B(+3.9%) |
| Dec 2023 | $45.81B(+3.3%) | $12.02B(+4.6%) | $45.81B(+1.8%) |
| Sep 2023 | - | $11.49B(+0.7%) | $44.99B(+1.1%) |
| Jun 2023 | - | $11.42B(+4.9%) | $44.48B(+1.5%) |
| Mar 2023 | - | $10.88B(-2.9%) | $43.84B(-1.2%) |
| Dec 2022 | $44.35B(+17.2%) | $11.21B(+2.0%) | $44.35B(-2.0%) |
| Sep 2022 | - | $10.98B(+2.0%) | $45.26B(+2.5%) |
| Jun 2022 | - | $10.77B(-5.4%) | $44.15B(+6.1%) |
| Mar 2022 | - | $11.39B(-6.0%) | $41.59B(+7.7%) |
| Dec 2021 | $37.83B(+37.1%) | $12.12B(+22.8%) | $38.61B(+12.2%) |
| Sep 2021 | - | $9.87B(+20.0%) | $34.41B(+10.0%) |
| Jun 2021 | - | $8.22B(-2.2%) | $31.29B(+6.4%) |
| Mar 2021 | - | $8.40B(+6.1%) | $29.40B(+6.1%) |
| Dec 2020 | $27.59B(+13.2%) | $7.92B(+17.4%) | $27.70B(+3.2%) |
| Sep 2020 | - | $6.75B(+6.7%) | $26.84B(+0.4%) |
| Jun 2020 | - | $6.33B(-5.6%) | $26.74B(+1.9%) |
| Mar 2020 | - | $6.70B(-5.0%) | $26.23B(+2.7%) |
| Dec 2019 | $24.38B(+10.4%) | $7.06B(+6.2%) | $25.54B(-0.7%) |
| Sep 2019 | - | $6.65B(+14.2%) | $25.73B(+3.7%) |
| Jun 2019 | - | $5.82B(-3.0%) | $24.80B(+0.6%) |
| Mar 2019 | - | $6.01B(-17.1%) | $24.66B(+3.5%) |
| Dec 2018 | $22.09B(-1.7%) | $7.25B(+26.6%) | $23.83B(+6.6%) |
| Sep 2018 | - | $5.72B(+0.7%) | $22.36B(-2.2%) |
| Jun 2018 | - | $5.68B(+9.7%) | $22.87B(+2.8%) |
| Mar 2018 | - | $5.18B(-10.4%) | $22.24B(-1.0%) |
| Dec 2017 | $22.46B(-2.3%) | $5.78B(-7.3%) | $22.46B(+0.9%) |
| Sep 2017 | - | $6.23B(+23.4%) | $22.27B(+2.5%) |
| Jun 2017 | - | $5.05B(-6.5%) | $21.74B(-2.5%) |
| Mar 2017 | - | $5.41B(-3.2%) | $22.29B(-3.1%) |
| Dec 2016 | $23.00B(-6.9%) | $5.58B(-2.0%) | $23.00B(-3.4%) |
| Sep 2016 | - | $5.70B(+1.7%) | $23.82B(-1.0%) |
| Jun 2016 | - | $5.60B(-8.4%) | $24.06B(-2.8%) |
| Mar 2016 | - | $6.12B(-4.4%) | $24.77B(+0.2%) |
| Dec 2015 | $24.71B(-6.9%) | $6.40B(+7.6%) | $24.71B(-1.3%) |
| Sep 2015 | - | $5.95B(-5.7%) | $25.02B(-2.6%) |
| Jun 2015 | - | $6.31B(+4.1%) | $25.69B(-1.7%) |
| Mar 2015 | - | $6.06B(-9.8%) | $26.14B(-1.5%) |
| Dec 2014 | $26.55B(+3.8%) | $6.72B(+1.6%) | $26.55B(-1.3%) |
| Sep 2014 | - | $6.61B(-2.3%) | $26.88B(+1.6%) |
| Jun 2014 | - | $6.76B(+4.7%) | $26.46B(+2.6%) |
| Mar 2014 | - | $6.46B(-8.4%) | $25.80B(+0.8%) |
| Dec 2013 | $25.59B(-8.2%) | $7.05B(+14.0%) | $25.60B(-1.2%) |
| Sep 2013 | - | $6.19B(+1.4%) | $25.91B(-1.8%) |
| Jun 2013 | - | $6.10B(-2.6%) | $26.38B(-2.0%) |
| Mar 2013 | - | $6.26B(-14.9%) | $26.91B(-3.3%) |
| Dec 2012 | $27.88B(-16.9%) | $7.36B(+10.4%) | $27.84B(-3.9%) |
| Sep 2012 | - | $6.66B(+0.5%) | $28.96B(-5.2%) |
| Jun 2012 | - | $6.63B(-7.8%) | $30.55B(-6.2%) |
| Mar 2012 | - | $7.19B(-15.1%) | $32.56B(-4.0%) |
| Dec 2011 | $33.54B(+0.7%) | $8.47B(+2.7%) | $33.92B(-1.0%) |
| Sep 2011 | - | $8.25B(-4.6%) | $34.27B(+1.2%) |
| Jun 2011 | - | $8.64B(+1.1%) | $33.88B(+2.8%) |
| Mar 2011 | - | $8.55B(-3.1%) | $32.97B(+0.6%) |
| Dec 2010 | $33.31B(+2.2%) | $8.83B(+12.3%) | $32.77B(-1.4%) |
| Sep 2010 | - | $7.86B(+1.6%) | $33.25B(-1.0%) |
| Jun 2010 | - | $7.73B(-7.4%) | $33.60B(-0.2%) |
| Mar 2010 | - | $8.36B(-10.2%) | $33.65B(+2.0%) |
| Dec 2009 | $32.61B(+2.3%) | $9.31B(+13.5%) | $32.99B(+7.6%) |
| Sep 2009 | - | $8.20B(+5.2%) | $30.65B(+2.5%) |
| Jun 2009 | - | $7.79B(+1.3%) | $29.91B(-0.4%) |
| Mar 2009 | - | $7.69B(+10.4%) | $30.02B(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2008 | $31.88B(+7.8%) | $6.97B(-6.7%) | $29.98B(-3.9%) |
| Sep 2008 | - | $7.46B(-5.5%) | $31.18B(+1.0%) |
| Jun 2008 | - | $7.90B(+3.3%) | $30.87B(+2.1%) |
| Mar 2008 | - | $7.65B(-6.4%) | $30.24B(+2.3%) |
| Dec 2007 | $29.56B(+11.6%) | $8.17B(+14.3%) | $29.56B(+3.6%) |
| Sep 2007 | - | $7.15B(-1.7%) | $28.54B(+2.3%) |
| Jun 2007 | - | $7.27B(+4.4%) | $27.91B(+2.6%) |
| Mar 2007 | - | $6.97B(-2.6%) | $27.19B(+3.1%) |
| Dec 2006 | $26.48B(+10.5%) | $7.15B(+9.8%) | $26.39B(+3.4%) |
| Sep 2006 | - | $6.52B(-0.6%) | $25.52B(+3.8%) |
| Jun 2006 | - | $6.56B(+6.5%) | $24.58B(+1.8%) |
| Mar 2006 | - | $6.16B(-2.0%) | $24.14B(+1.3%) |
| Dec 2005 | $23.95B(+11.8%) | $6.29B(+12.6%) | $23.84B(+2.1%) |
| Sep 2005 | - | $5.58B(-8.7%) | $23.36B(+1.1%) |
| Jun 2005 | - | $6.11B(+4.3%) | $23.09B(+3.0%) |
| Mar 2005 | - | $5.86B(+1.1%) | $22.43B(+1.8%) |
| Dec 2004 | $21.43B(+13.7%) | $5.80B(+9.0%) | $22.03B(+4.4%) |
| Sep 2004 | - | $5.32B(-2.5%) | $21.11B(+2.4%) |
| Jun 2004 | - | $5.45B(-0.2%) | $20.61B(+4.8%) |
| Mar 2004 | - | $5.46B(+12.1%) | $19.66B(+3.1%) |
| Dec 2003 | $18.85B(+5.6%) | $4.88B(+1.2%) | $19.08B(-0.1%) |
| Sep 2003 | - | $4.81B(+6.8%) | $19.11B(+1.3%) |
| Jun 2003 | - | $4.51B(-7.6%) | $18.86B(+0.5%) |
| Mar 2003 | - | $4.88B(-0.4%) | $18.77B(+2.5%) |
| Dec 2002 | $17.84B(+8.3%) | $4.90B(+7.4%) | $18.31B(+2.6%) |
| Sep 2002 | - | $4.57B(+3.3%) | $17.85B(+3.7%) |
| Jun 2002 | - | $4.42B(-0.0%) | $17.22B(+2.4%) |
| Mar 2002 | - | $4.42B(-0.4%) | $16.82B(+2.9%) |
| Dec 2001 | $16.48B(+4.3%) | $4.44B(+12.8%) | $16.34B(+17.8%) |
| Sep 2001 | - | $3.93B(-2.1%) | $13.87B(-1.1%) |
| Jun 2001 | - | $4.02B(+1.8%) | $14.02B(-9.2%) |
| Mar 2001 | - | $3.95B(+100.8%) | $15.44B(+0.4%) |
| Dec 2000 | $15.80B(+44.3%) | $1.97B(-51.9%) | $15.37B(+1.0%) |
| Sep 2000 | - | $4.09B(-24.8%) | $15.22B(-1.3%) |
| Jun 2000 | - | $5.44B(+40.0%) | $15.41B(+6.3%) |
| Mar 2000 | - | $3.88B(+114.3%) | $14.50B(-4.2%) |
| Dec 1999 | $10.95B(+19.9%) | $1.81B(-57.7%) | $15.13B(-12.9%) |
| Sep 1999 | - | $4.28B(-5.4%) | $17.38B(+12.6%) |
| Jun 1999 | - | $4.52B(0.0%) | $15.43B(+9.4%) |
| Mar 1999 | - | $4.52B(+11.4%) | $14.10B(+17.5%) |
| Dec 1998 | $9.13B(+7.4%) | $4.06B(+74.2%) | $12.00B(+17.3%) |
| Sep 1998 | - | $2.33B(-27.0%) | $10.23B(+2.3%) |
| Jun 1998 | - | $3.19B(+32.0%) | $10.00B(+10.0%) |
| Mar 1998 | - | $2.42B(+5.7%) | $9.09B(+1.5%) |
| Dec 1997 | $8.51B(+1.7%) | $2.29B(+9.0%) | $8.96B(-20.2%) |
| Sep 1997 | - | $2.10B(-8.1%) | $11.22B(-1.9%) |
| Jun 1997 | - | $2.28B(0.0%) | $11.44B(+0.0%) |
| Mar 1997 | - | $2.28B(-49.9%) | $11.43B(+0.0%) |
| Dec 1996 | $8.37B(+8.2%) | $4.56B(+97.0%) | $11.43B(+32.4%) |
| Sep 1996 | - | $2.31B(+1.5%) | $8.63B(+4.6%) |
| Jun 1996 | - | $2.28B(0.0%) | $8.26B(+3.3%) |
| Mar 1996 | - | $2.28B(+29.2%) | $7.99B(+3.4%) |
| Dec 1995 | $7.73B(+12.7%) | $1.76B(-8.9%) | $7.73B(-0.8%) |
| Sep 1995 | - | $1.94B(-4.1%) | $7.80B(+2.4%) |
| Jun 1995 | - | $2.02B(-0.0%) | $7.61B(+2.4%) |
| Mar 1995 | - | $2.02B(+10.4%) | $7.43B(+2.5%) |
| Dec 1994 | $6.86B(+2.9%) | $1.83B(+4.2%) | $7.25B(+4.2%) |
| Sep 1994 | - | $1.75B(-4.6%) | $6.96B(+3.2%) |
| Jun 1994 | - | $1.84B(0.0%) | $6.74B(+1.3%) |
| Mar 1994 | - | $1.84B(+19.8%) | $6.66B(+1.3%) |
| Dec 1993 | $6.67B(-4.6%) | $1.53B(-0.2%) | $6.57B(+30.5%) |
| Sep 1993 | - | $1.54B(-12.1%) | $5.03B(+44.0%) |
| Jun 1993 | - | $1.75B(0.0%) | $3.50B(+100.0%) |
| Mar 1993 | - | $1.75B | $1.75B |
| Dec 1992 | $6.98B(+0.8%) | - | - |
| Dec 1991 | $6.93B(+2.4%) | - | - |
| Dec 1990 | $6.77B | - | - |
FAQ
- What is AstraZeneca PLC annual revenue?
- What is the all time high annual revenue for AstraZeneca PLC?
- What is AstraZeneca PLC annual revenue year-on-year change?
- What is AstraZeneca PLC quarterly revenue?
- What is the all time high quarterly revenue for AstraZeneca PLC?
- What is AstraZeneca PLC quarterly revenue year-on-year change?
- What is AstraZeneca PLC TTM revenue?
- What is the all time high TTM revenue for AstraZeneca PLC?
- What is AstraZeneca PLC TTM revenue year-on-year change?
What is AstraZeneca PLC annual revenue?
The current annual revenue of AZN is $54.10B
What is the all time high annual revenue for AstraZeneca PLC?
AstraZeneca PLC all-time high annual revenue is $54.10B
What is AstraZeneca PLC annual revenue year-on-year change?
Over the past year, AZN annual revenue has changed by +$8.28B (+18.08%)
What is AstraZeneca PLC quarterly revenue?
The current quarterly revenue of AZN is $14.63B
What is the all time high quarterly revenue for AstraZeneca PLC?
AstraZeneca PLC all-time high quarterly revenue is $14.75B
What is AstraZeneca PLC quarterly revenue year-on-year change?
Over the past year, AZN quarterly revenue has changed by +$1.69B (+13.06%)
What is AstraZeneca PLC TTM revenue?
The current TTM revenue of AZN is $56.53B
What is the all time high TTM revenue for AstraZeneca PLC?
AstraZeneca PLC all-time high TTM revenue is $56.53B
What is AstraZeneca PLC TTM revenue year-on-year change?
Over the past year, AZN TTM revenue has changed by +$7.40B (+15.06%)